Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
10,500
+160 (1.55%)
At close: Dec 5, 2025
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 244.20 billion as of December 5, 2025. Its market cap has decreased by -16.31% in one year.
Market Cap
244.20B
Enterprise Value
206.16B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
10,500.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 244.20B, an increase of 52.40%. That is a compound annual growth rate of 8.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 244.20B | 1.83% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 709.49T |
| SK hynix | 375.61T |
| LG Energy Solution | 99.68T |
| Samsung Biologics | 75.96T |
| Hyundai Motor Company | 68.19T |
| Doosan Enerbility | 51.49T |
| Kia Corporation | 47.79T |
| HD Hyundai Heavy Industries | 47.40T |